Iowa State University and Nanovaccine Institute researchers, including Morrill Professor Don Sakaguchi from genetics, development and cell biology, are working to develop nanocarriers that deliver drugs across the blood brain barrier, a high hurdle created by the body to protect the brain from pathogens. Successful nanocarriers could lead to treatments for brain disorders including Alzheimer's disease, Parkinson’s disease, ischemic stroke, epilepsy and seizures.

Learn about this research in the ISU News Service article, "Researchers test hybrid, soft/hard nanocarriers to deliver drugs to the brain."